https://www.selleckchem.com/pr....oducts/epoxomicin-bu
Furthermore, our meta-analysis, including eight studies, indicated that a high CES1 expression predicted better outcomes among prostate cancer patients (hazard ratio 0.82, 95% confidence interval 0.70-0.97, P = 0.02). In conclusion, our findings suggest that CES1 rs8192935 and rs8192950 are associated with BCR and that CES1 plays a tumor suppressive role in prostate cancer.The aim of this study was to examine the effect of running exercise modality on oxidative stress. Thirteen endurance athletes (age 21.46 ± 0.66 years) per
Like
Comment
Share
